| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 9 | |
| #2 | United Kingdom | 7 | |
| #3 | Australia | 3 | |
| #4 | Mexico | 3 | |
| #5 | Canada | 2 | |
| #6 | China | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology | |
| #4 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Peptides | |
| #3 | Therapeutic chemical compounds | |
| #4 | Climate change mitigation in goods production | |
| #5 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Howard Philip Wilson | 15 |
| #2 | Van Berkel Patricius Hendrikus Cornelis | 14 |
| #3 | Philip Wilson Howard | 3 |
| #4 | Patricius Hendrikus Cornelis Van Berkel | 3 |
| #5 | Williams David G | 1 |
| #6 | Van Berkel Patricius Henrikus Cornelis | 1 |
| Publication | Filing date | Title |
|---|---|---|
| GB202015226D0 | Pyrrol obenzodiazepine-antibody conugates and uses thereof | |
| GB201811332D0 | Pyrroloobenzodiazepine-antibody conjugates | |
| GB201803298D0 | Dosage regime | |
| GB201802679D0 | Dosage regime | |
| GB201802172D0 | Treatment of Car T-Cell Toxicity | |
| GB201720544D0 | Dosage regime | |
| GB201719398D0 | Pyrrolobenzodiazepine-antibody conjugates | |
| US2018092986A1 | Site-specific antibody-drug conjugates | |
| AU2016247504A1 | Site-specific antibody-drug conjugates |